ArkeaBio

ArkeaBio is at the forefront of agricultural bioscience, pioneering interventions to address climate change by targeting methane emissions from cattle. The company is developing an innovative vaccine that demonstrates the ability to reduce methane emissions, which contribute significantly to global warming, equating to the impact of all passenger vehicles worldwide. The vaccine is designed to be a safe, cost-effective, and scalable solution, poised to create substantial value across the agricultural value chain by lowering emissions and enhancing feed efficiency without impacting meat or milk safety. ArkeaBio's vaccine offers a practical approach that supports farmers, governments, and food producers in their efforts to transition toward more sustainable livestock farming practices. Industry leaders like Breakthrough Energy Ventures and Rabo Ventures recognize its potential as a critical tool in decarbonizing livestock and mitigating climate change. The company's technology is advancing toward commercialization, promising outsized climatic benefits and economic advantages for those involved in livestock production.